Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 66

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 3
Chunk 66
---
 these agreements, we use the licensed
intellectual property in an unauthorized manner or we are subject to bankruptcy-related proceedings, the terms of the licenses may be
materially modified, such as by rendering currently exclusive licenses non-exclusive, or it may give our future licensors the right to
terminate their respective agreement with us, which could limit our ability to implement our current business plan and materially adversely
affect our business, financial condition, results of operations and prospects. In addition, disputes may arise between us and our future
licensors regarding intellectual property subject to a license agreement, including: (i) the scope of rights granted under the license
agreement and other interpretation-related issues; (ii) whether and the extent to which our technology and processes infringe on intellectual
property of the licensor that is not subject to the license agreement; (iii) our right to sublicense patents and other rights to third
parties; (iv) our diligence obligations with respect to the use of the licensed technology in relation to our development and commercialization
of our product candidates, and what activities satisfy those diligence obligations; (v) our right to transfer or assign the license; and
(vi) the ownership of inventions and know-how resulting from the joint creation or use of intellectual property by our future licensors
and us and our partners. If disputes over intellectual property that we license in the future prevent or impair our ability to maintain
our licensing arrangements on acceptable terms, we may not be able to successfully develop and commercialize the affected product candidates,
which would have a material adverse effect on our business.

In addition, certain of our
future agreements with third parties may limit or delay our ability to consummate certain transactions, may impact the value of those
transactions, or may limit our ability to pursue certain activities. For example, we may in the future enter into license agreements that
are not assignable or transferable, or that require the licensor’s express consent in order for an assignment or transfer to take
place.

We may be involved in lawsuits or litigation
to protect or enforce our patents or other intellectual property, which could result in substantial costs and liability and prevent us
from commercializing our potential products.

Competitors may infringe our
patents, trademarks or other intellectual property. To counter infringement or unauthorized use, we may be required to take legal action
to enforce our patents against such infringing activity. Such enforcement proceedings against infringers can be expensive and time-consuming.
Any such claims could provoke these parties to assert counterclaims